These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23879911)

  • 21. Can prostate specific antigen derivatives reduce the frequency of unnecessary prostate biopsies?
    Klein EA
    J Urol; 1996 Aug; 156(2 Pt 1):443-4. PubMed ID: 8683698
    [No Abstract]   [Full Text] [Related]  

  • 22. Repeat Prostate-Specific Antigen Tests Before Prostate Biopsy Decisions.
    Nordström T; Adolfsson J; Grönberg H; Eklund M
    J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27418620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A large, benign prostatic cyst presented with an extremely high serum prostate-specific antigen level.
    Chen HK; Pemberton R
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26746834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The era of serum prostate specific antigen as a marker for biopsy of the prostate and detecting prostate cancer is now over in the USA.
    Stamey TA
    BJU Int; 2004 Nov; 94(7):963-4. PubMed ID: 15541106
    [No Abstract]   [Full Text] [Related]  

  • 25. [PSAD and PSA-AD in the early diagnosis of cancer of the prostate].
    Allepuz Losa C; Sanz JI; Carela J; Benejam J; García-Miralles R; Rioja Sanz LA
    Actas Urol Esp; 1997 Oct; 21(9):843-51. PubMed ID: 9471867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive analysis of post-diagnostic prostate-specific antigen kinetics as predictor of a prostate cancer progression in active surveillance patients.
    Iremashvili V; Manoharan M; Lokeshwar SD; Rosenberg DL; Pan D; Soloway MS
    BJU Int; 2013 Mar; 111(3):396-403. PubMed ID: 22703025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. It ain't what you do, it's the way you do it: five golden rules for transforming prostate-specific antigen screening.
    Vickers A; Carlsson S; Laudone V; Lilja H
    Eur Urol; 2014 Aug; 66(2):188-90. PubMed ID: 24411991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Total PSA, PSA density and biopsy Gleason score in predicting the pathologic stage of prostate cancer].
    Liu S; Lü JJ; Fu Q; Zhang H; Gao DX; Liu Z
    Zhonghua Nan Ke Xue; 2010 May; 16(5):415-9. PubMed ID: 20684321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re: Billis et al.: Does the type of prostatic atrophy influence the association of extent of atrophy in needle biopsies and serum prostate-specific antigen levels? (Urology 2009;74:1111-1115).
    Papatsoris A; Albanis S; Deliveliotis C
    Urology; 2010 May; 75(5):1239; author reply 1240. PubMed ID: 20451754
    [No Abstract]   [Full Text] [Related]  

  • 30. PSA scores: should we use a lower threshold?
    Carter HB
    Johns Hopkins Med Lett Health After 50; 2004 Oct; 17(8):6. PubMed ID: 15602780
    [No Abstract]   [Full Text] [Related]  

  • 31. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
    Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
    J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer.
    Ochiai A; Fritsche HA; Babaian RJ
    Urology; 2005 Oct; 66(4):819-23. PubMed ID: 16230145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining prostate cancer risk before prostate biopsy.
    Pal RP; Maitra NU; Mellon JK; Khan MA
    Urol Oncol; 2013 Nov; 31(8):1408-18. PubMed ID: 22795499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
    Ghafoori M; Varedi P; Hosseini SJ; Asgari M; Shakiba M
    Urol J; 2009; 6(3):182-8. PubMed ID: 19711272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PSA density improves prediction of prostate cancer.
    Verma A; St Onge J; Dhillon K; Chorneyko A
    Can J Urol; 2014 Jun; 21(3):7312-21. PubMed ID: 24978363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients.
    Washino S; Okochi T; Saito K; Konishi T; Hirai M; Kobayashi Y; Miyagawa T
    BJU Int; 2017 Feb; 119(2):225-233. PubMed ID: 26935594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PSA: the plot thickens.
    Health News; 2003 Oct; 9(10):15. PubMed ID: 14619777
    [No Abstract]   [Full Text] [Related]  

  • 38. Association of serum prostate-specific antigen levels with the results of the prostate needle biopsy.
    Janbaziroudsari H; Mirzaei A; Maleki N
    Bull Cancer; 2016 Sep; 103(9):730-4. PubMed ID: 27345449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [PSA volume quotient: an additional parameter in diagnosis of locally confined prostate cancer].
    Gottfried HW; Kleinschmidt K; Flohr P; Miller K; Hautmann R
    Urologe A; 1993 Nov; 32(6):455-9. PubMed ID: 7506850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between immunohistochemical patterns and serum levels of PSA and PSAP in prostatic pathology: evaluation of 198 prostatic fine needle biopsies.
    Vitali A; Ardoino S; Durante P; Ferro MA; Li Causi F; Parodi C; Sanguineti G; Gaffuri M; Paerachino M; Salvadori RP
    Anticancer Res; 1994; 14(4A):1503-7. PubMed ID: 7526771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.